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Urinary excretion of neutral proteinases in nephrotic rats with a
glomerular disease. A proliferative glomerulonephritis was induced in
rats pre-immunized with rabbit IgG by injecting intravenously a sub-
nephrotoxic dose of rabbit anti-glomerular basement membrane (GBM)
IgG (A rats). Most rats (80%) developed a severe proteinuria (>100
mg124 hr) within two to five days after the injection of anti-GBM IgG. At
the same time, microscopic examination of the kidneys revealed a
glomerular infiltration by mononuclear phagocytes and a prominent
decrease in the intensity of the colloidal iron reaction in glomeruli. A
non-proliferative glomerular disease was induced in another group of
rats (B rats) by intraperitoneal administration of aminonucleoside of
puromycin. A marked proteinuna (>100 mg124 hr) occurred after six
days in 90% of animals. Histochemical studies then revealed a decrease
in staining intensity of glomeruli for polyanion. No glomerular
hypercellularity was noted. In normal rats and in non-proteinuric A or
B rats, the 24 hour urinary excretion of neutral proteinases ranged from
1.4 to 7.8 units (mean value SaM, 4.69 0.60, N = 11), that of laminin
ranged from 100 to 3,900 ng (mean value SEM, 1,154 325, N = 10),
and that of type IV collagen ranged from 160 to 420 ng (mean value
SEM, 306 26.5 ng, N = 8). In proteinuric rats from groups A (N = 11)
and B (N = 9), the 24 hour urinary excretion of neutral proteinases
significantly increased (mean values SEM, 38.55 8.66 U for A rats
and 42.17 7.92 U for B rats) and ran parallely with that of proteins,
laminin and type IV collagen. Significant direct linear correlations were
observed between: (a) the urinary neutral proteinase activity and the
proteinuria, the urinary excretion of laminin and that of type IV
collagen; and (b) the proteinuria and the urinary excretion of laminin. In
A and B rats, as in normal rats, proteinase activity occurred in urine as
an active form exhibiting an apparent molecular weight of 30,000 and an
isoelectric point of 9.0, was maximal in the neutral range, was elimi-
nated by heating at 60°C for 30 minutes and was found capable of
degrading GBM polypeptides (laminin and type IV collagen) in vitro. In
normal urine, a significant inhibition of the neutral proteinase activity
was seen with phenylmethylsulfonylfluoride, soybean trypsin inhibitor
or aprotinin, but not with EDTA or cysteine, which suggests that the
enzymatic activity mainly results from (a) serine proteinase(s). In urine
from A or B rats, neutral proteinase activity was significantly reduced
by all the inhibitors tested which indicates the presence of both (a)
serine proteinase(s) and (a) metallo-proteinase(s). Our in vitro and in
vivo findings strongly suggest that in these two experimental models of
glomerular disease, neutral metalloproteinases may be involved in the
damage to the GBM and in the development of proteinuria.
The impermeability of the glomerular filtration barrier to
anionic proteins is partly due to its electronegative charges, as
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suggested by the following observations: (1) polycations selec-
tively bind to the glomerular epithelial cells, their pedicelles,
the endothelial cell coat and the laminae rarae [1—4]; (2) this
binding is decreased in experimental models of proteinuria such
as the aminonucleoside nephrosis (AN) [5, 6] and the
nephrotoxic nephritis (NTN) [7]; (3) the filtration fraction of
cationic dextrans is higher than that of anionic dextrans in
normal rats [8]; and (4) the filtration fraction of anionic dextrans
is higher in AN and NTN rats than in normal rats [6, 9].
The biochemical knowledge of the electronegative molecules
present in the glomerular filtration barrier is in progress. It has
been shown [10] that sialic acid is one of these molecules, since
neuraminidase infusion into rats induces a loss of anionic
charges of epithelial and endothelial cells [10]. The same
authors have also demonstrated that GBM glycosaminoglycans
play a major role in the restricted transport of polyanions across
the glomerular capillary wall [11].
The ability to obtain reliable growths of glomerular cells in
culture has allowed the study of the biosynthesis and degrada-
tion of GBM components in vitro. It has been shown [12—15]
that the epithelial and mesangial cells contribute to the biosyn-
thesis of type IV collagen, non-collagenous glycoproteins and
glycosaminoglycans. Neutral proteinases generated by cells
derived from the glomerular mesangium are capable of degrad-
ing GBM glycoproteins in vitro [16]. In immunological glomer-
ulonephritis (GN), monocytes and neutrophils frequently infil-
trate the glomerulus [17, 18]. These cells also contain neutral
proteinases which extensively degrade the GBM at physiolog-
ical pH [19, 20]. These findings suggest that neutral proteinases
may be implicated in the physiological turnover and in the
increased degradation of GBM anionic proteins in vivo.
In this work, we have first studied the urinary neutral
proteinase activity and the urinary excretion of GBM compo-
nents, that is, laminin and type IV collagen, in normal rats. We
have then measured the same parameters in the urine from rats
presenting with a glomerular disease and a severe proteinuria in
order to provide a support to the concept that neutral
proteinases may play a role in the damage to the GBM. Since
neutral proteinases can be generated in vitro by intrinsic
glomerular cells as well as by inflammatory cells, we have also
compared the urinary excretion of these enzymes during the
course of two experimental models of glomerular diseases, that
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is, a non-proliferative glomerular disease and a GN associated
with an infiltration of glomeruli by mononuclear phagocytes.
Methods
The experimental model of nephrotoxic nephritis (NTN)
Nephrotoxic serum was prepared as previously described
[21, 221. Briefly, rabbits were immunized by intramuscular
injection of 5 mg of lyophilized GBM emulsified in complete
Freud's adjuvant (Difco Laboratories, Detroit, Michigan,
USA). One injection was given each week for three weeks,
followed by a single injection three weeks later. The rabbit
serum was absorbed for hemagglutinins and decomplemented.
IgG fraction was isolated by passage through DEAE-cellulose
columns [231. The presence and specificity of anti-GBM IgG
were demonstrated by radioimmunoassay [22] and by indirect
immunofluorescence performed on normal rat kidney slices
[24]. A linear deposition of IgG was observed along the GBM,
the tubular basement membranes and the Bowman's capsules.
Sprague Dawley (female) rats weighing 100 to 120 g were
pre-immunized with 1 mg of rabbit IgG in 0.5 ml of complete
Freud's adjuvant injected intraperitoneally. One week later, the
rats received 1 mg of rabbit anti-GBM IgG intravenously. This
dose was chosen on the basis of preliminary experiments
demonstrating that 1 to 2 mg of rabbit anti-GBM IgG did not
induce a significant proteinuria in non-preimmunized rats [251.
The experimental model of aminonucleoside of puromycin
nephrosis (PAN)
A nephrotic syndrome was induced in Sprague Dawley rats
weighing 100 to 120 g by the administration of aminonucleo side
of puromycin (Sigma Chemical Co., St. Louis, Missouri, USA)
in a single intraperitoneal injection of 150 mg per kg. Animals
were sacrificed three to 24 days after administration of
aminonucleoside [261.
Assessment of urinary neutral proteinase activity
Methods described in the present paper have been exten-
sively detailed [19, 27]. Briefly, 24 hour urine collections were
exhaustively dialyzed at 4°C against distilled water, were ster-
ilized by filtration through Millipore filters (Millipore Benelux,
Brussels) and were then stored at —20°C until use. Neutral
proteolytic activity against azocasein (Azocoll, Caibio-
chem—Behring Corp., La Jolla, California, USA) or 3H-labelled
acetylcasein was determined on 0.2 ml urine samples according
to the method described by Starkey [27], except that a temper-
ature of 45°C was used [191. 3H-Iabelled acetylcasein was used
as a substrate for screening purposes, whereas the precise
measurement of the urinary enzyme activity was performed
using azocasein as a substrate. Under the conditions of the
assay, the enzyme activity was linear with time and with
enzyme concentration. Enzyme activity is expressed in units
per ml, where one unit is defined as the amount of enzyme that
will hydrolyze 1 mg of substrate per hour. In order to identify
which enzyme was responsible for the degradation of sub-
strates, experiments with various inhibitors of tissue
proteinases were undertaken [16, 20]. The following inhibitors
were tested: EDTA 2 m or 15 mM, cysteine 2 mM, soybean
trypsin inhibitor (SBTI) (100 and 500 ig/ml), aprotinin
(Trasylol) (500 tg and 1 mg/ml) and phenylmethylsulfonylflu-
oride (PMS-F) 1 mM. Enzyme activity was then expressed as
the percentage of activity in the absence of inhibitors. Finally,
the pH optimum of the neutral proteinase activity was deter-
mined by varying urine pH over a range of 6.0 to 8.5, and
thermolability was assessed by heating urine samples to 60°C
for 30 minutes before testing.
In order to study the effects of neutral proteinases on BM
components, [14C1-labelled type IV collagen or [3H1-laminin
were prepared as previously described [28, 29]. The purity of
the preparations was assessed by polyacrylamide slab gel
electrophoresis [141. Five tg of labelled BM polypeptides
(about 5,000 cpm) were added to 0.2 ml of 0.02 M Tris-HC1
buffer pH 7.6, containing 10 mM CaCI2, 0.05% NaN3, penicillin
(100 U/mi) and streptomycin (100 sg/ml). Dialyzed urine sam-
ples (0.2 ml) were then incubated with the labelled BM
glycoproteins for 48 hours at 37°C. At the end of the incubation,
the samples were exhaustively dialyzed against distilled water
and their radioactivity was counted in a Packard Tricarb
Counter after addition of 10 ml of Bray's solution [29]. Controls
included BM glycoproteins added to buffer alone (0.4 ml) or to
urine samples (0.2 ml) supplemented with PMS-F 1 m and
EDTA 2 m. Each experiment was done in triplicate. Results
are expressed as the percentage of the radioactivity counted in
control samples. Enzyme inhibition profiles were obtained
using the same conditions as described above for azocaseinase.
Gel chromatography for the determination of apparent molec-
ular weights was performed using a 1.5 x 60 cm Sephacryl
S-200 SF column (Pharmacia, Uppsala, Sweden) [161. Isoelec-
tric points were determined with the chromatofocusing kit
provided by Pharmacia Fine chemicals. Columns (1.6 >< 40cm,
Pharmacia) were packed with PBE 94 gel. The start buffers used
were 0.025 M ethanolamine-CH3COOH pH 9.4 for the pH range
from 9 to 6 and 0.025 M imidazole-HC1 pH 7.4 for the pH range
from 7 to 4; the polybuffers 96-CH3COOH pH 6 and 74-HCI pH
4.0 were used as eluents for the former and the latter pH range,
respectively.
Assessment of proteinuria and of urinary laminin or type IV
collagen excretions
Urine was collected at 24 hour intervals and protein concen-
trations were measured by the method of Kingsbury and Clarck
[30]. The urinary excretion of laminin and of type IV collagen
was also determined on 24 hour urine collections by a solid
phase radioimmunoassay using affinity purified, anti-laminin or
anti-type IV collagen rabbit antibodies and 1251-protein A as a
tracer [31, 321. The specificity of these antibodies and the
reproducibility of radioimmunoassays have been previously
described [31, 321. Standard curves were established by mixing
10 to 1,000 ng of either laminin or type IV collagen to 1 ml of
phosphate buffered—saline, pH 7.4. Results were expressed in
ng per 24 hours.
Morphological studies of the kidney sections
The kidney were examined by light and immunofluorescence
microscopy at various periods of time, from three to 21 days,
after the injection of anti-GBM IgG or of aminonucleoside. For
light microscopy, portions of rat kidneys were fixed in Bouin's
renal fixative, sectioned at 4 m and stained with hematoxylin
and eosin, periodic acid—Schiff reagent and with colloidal iron at
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pH 1.9 [5]. Kidney specimens were also snap frozen in liquid
nitrogen, sectioned at 2 pm on a cryostat and stained with
fluorescein isothiocyanate (FITC) conjugated antisera to rabbit
IgG, rat Ig and rat C3. Commercial FITC-antisera were used
(Behring—Werke AG, MarburglLahn, West Germany). The
kidney sections were also incubated for 30 minutes at room
temperature with fluorescein—conjugated rabbit IgG directed
against laminin or type IV collagen. The specificity of these
antibodies has been previously demonstrated [33].
Results
The experimental model of NTN (A rats)
The morphological aspect of glomeruli within two to five days
after the injection of anti-GBM IgG has been previously de-
scribed [25]. Briefly, microscopic examination of the kidneys
revealed a glomerular hypercellularity which was the conse-
quence of an infiltration by mononuclear cells and a prolifera-
tion of intrinsic glomerular cells. No crescents were seen. After
two to three weeks, there was a progressive thickening of the
GBM and a simultaneous decrease of the hypercellularity [25].
Immunofluorescence study of GN kidneys demonstrated the
presence of linear deposits of rat Ig, rat C3 and rabbit IgG along
the GBM. No fixation was detectable on other kidney struc-
tures [25].
The experimental model of PAN (B rats)
In this model, no glomerular hypercellularity was observed;
as others [5, 26], we only noted multiple small eosinophilic
droplets in glomerular epithelial cells and eosinophilic hyaline
casts in some Bowman's spaces and tubular lumens. Some
proximal convoluted tubules showed epithelial fragmentation
and collapse. These changes were particularly obvious between
five and 12 days after PAN injection. By 21 days, glomeruli and
tubules were indistinguishable from those of normal rats. At the
same time, PAN kidney specimens were not significantly dif-
ferent from those of normal rats with respect to the presence of
IgG and C3. A slight increase in staining for 1gM in an
indeterminate pattern was however observed in glomeruli from
PAN rats (data not shown).
Proteinuria
Control values for total 24 hour urinary protein excretions in
the rats used in this study did not exceed 10 mg. Rats injected
with 1 to 2 mg of rabbit anti-GBM IgG did not develop a
pathological proteinuria. Pre-immunization with I mg of rabbit
IgG seven days before the injection of 1 mg of anti-GBM IgG
induced a severe proteinuria starting on day two and reaching
maximum values on day four. The proteinuria decreased there-
after to reach about 50 mg/day three weeks later (Fig. lA).
Figure lB shows the evolution of the 24 hour urinary protein
excretions following the injection of PAN. A proteinuria ap-
peared after a delay of six days, increased to a maximum value
of 180 mg per 24 hours on day 12 and progressively declined to
reach near—normal values by 22 to 24 days. The mean protein-
uria (± sEM) was 240 23 mg/24 hours on day four in A rats
(range, 110 to 420 mg/24 hr, N = 11), whereas it was 180 31
mg/24 hours on day 12 in B rats (range, 95 to 310 mg/24 hr, N
9). Both groups of rats therefore developed a severe and
comparable proteinuria.
Urinary neutral proteinase activity
Proteinase activity against azocasein, 3H-labelled acetylcase-
in, was present in the urine from normal, A or B rats. This
enzymatic activity was destroyed by heating at 60°C for 30
minutes and was maximal in the neutral range. Less than 60%
activity were indeed detectable below pH 7.0 or above pH 8.0
(data not shown). In nine normal rats, the urinary neutral
proteinase activity ranged from 1.4 to 7.8 U/24 hours (mean
value sEM: 4.69 0.60) (Fig. 2). In 11 NTN rats tested four
days after the injection of anti-GBM IgG, the urinary neutral
proteinase activity was strongly increased (mean value SEM,
38.55 8.66 U/24 hr, range, 12.3 to 105.6 U/24 hr, Fig. 2). In B
rats, the urinary neutral proteinase activity measured on day 12
was 42.17 7.92 U/24 hours (range, 15.92 to 83.7 U/24 hr, N =
9, Fig. 2). The differences observed between the urinary neutral
proteinase activity of normal and A rats, and between that of
normal and B rats, were all statistically significant (P < 0.001).
The urinary neutral proteinase activity was sequentially mea-
sured in four rats from group A and in two rats from group B.
It was found that the 24 hour urinary excretion of neutral
proteinases was maximal on day four for A rats and on day 12
for B rats, as that of proteins (data not shown).
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Fig. 1. Evolution oftheproteinuria in rats injected with anti-GBM IgG(A) or in rats injected with aminonucleoside (B). Values of proteinuria
are expressed in mg par 24 hr (±5EM). In each group, proteinuria was
measured in eight rats at least.
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Fig. 2. Urinary neutral proteinase activity in nine normal rats (N), 11
NTN rats (A) on day four and nine PAN nephrosis rats (B) on day 12.
Results are expressed in units (U) per 24 hr. One unit is the amount of
enzyme hydrolyzing 1 mg of substrate per hour. Horizontal lines
indicate means SEM. A and B values are significantly higher than N
values (P < 0.001).
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Fig. 3. A. Urinary laminin excretion in 10 normal rats (N), 11 NTN
rats (A) on day four and nine PAN rats (B) on day 12. Results are
expressed in nannograms/24 hr. Horizontal lines indicate means SEM.
A and B values are significantly higher than N values (P < 0.001). B.
Urinary type IV collagen excretion in seven normal rats (N), 11 NTN
rats (A) on day four and nine PAN rats (B) on day 12.
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Urinary excretion of laminin and type IV collagen
In normal rats, the urinary laminin excretion was 1,154 325
ng/24 hours (mean value SEM, range 100 to 3,000 ng/24 h, N
= 10, Fig. 3), whereas the urinary type IV collagen excretion
was 306 36.5 ng/24 hours (mean value SEM, range, 160 to
420 ng124 hr, N = 8, Fig. 3). In A rats tested four days after the
injection of anti-GBM IgG, the mean urinary excretion of
laminin (±sEM) was 12,371 2,205 ng124 hours (range, 6,900 to
38,400 ng/24 hr, N = 11, Fig. 3). In B rats, the mean urinary
excretion of laminin (± suM), measured 12 days after PAN
injection, reached 15,878 3,038 ng/24 hours (range, 8,100 to
38,800 ng124 hr, N = 9, Fig. 3). The mean urinary laminin
excretion per day was therefore significantly higher in nephrotic
than in normal rats (P < 0.001). Comparable data were obtained
for the urinary excretion of type IV collagen (Fig. 3). Finally, it
was found that the urinary excretions of laminin or of type IV
collagen in A and B rats were not statistically different. The
urinary excretion of laminin and of type IV collagen was
measured in four NTN rats and in two PAN rats on two
different days after injection of either nephrotoxic serum or
aminonucleoside. Figure 4 clearly shows that the 24 hour
urinary excretion of both structural glycoproteins ran parallel
with that of proteins (Figure 1).
In both groups of nephrotic rats, significant direct linear
correlations were observed between the following parameters:
(1) the proteinuria and the urinary proteinase activity (Fig. 5);
(2) the proteinuria and the urinary excretion of laminin (Fig. 5);
and (3) the urinary neutral proteinase activity and the urinary
excretion of either laminin or of type IV collagen (Fig. 6).
Some properties of urinary neutral proteinases
In order to characterize the proteinase activity, urine samples
from normal, A and B rats were preincubated with various
proteolytic enzyme inhibitors (Table 1). In normal A and B rats,
a marked inhibition of the enzymatic activity was obtained by
the serine proteinase inhibitors (PMS-F, SBTI and aprotinin),
whereas the metallo-proteinase inhibitors (EDTA and cysteine)
inhibited the enzymatic activity in urine from A and B rats only.
Gel chromatography of normal or nephrotic urine showed an
active neutral proteinase activity peak with an apparent molec-
ular weight of 30,000 daltons (Fig. 7). Furthermore, chromato-
focusing experiments revealed that the isoelectric point of
active enzymes in normal or nephrotic urine was about 9.0 (Fig.
8). Finally, the ability of urine from normal, A or B rats to
degrade laminin and type IV collagen is shown in Table 2. In
control urines, the degradation of both glycoproteins was lower
than 10% after otherwise identical experimental conditions,
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which confirms the inhibitory properties of EDTA and PMSF
on the urinary azocaseinase activity (Table 1).
Relation between the urinary neutral proteinase activity and
the immunohistochemical studies of glomeruli
Sequential histochemical studies were conducted on kidney
sections from NTN rats or from puromycin—treated animals at
varying intervals after the nephrotoxic serum or the drug was
administered. In each rat with a proteinuria and with a signifi-
cant increase in the urinary neutral proteinase activity, a
decrease and alteration in the staining intensity for glomerular
polyanion was apparent when compared with kidney sections
from normal rats (Table 3). Despite this fact, the pattern of
staining and the intensity of binding to glomerular structures of
antibodies directed against laminin (and type IV collagen) were
not strongly altered in A or B rats, as shown by immuno-
fluorescence microscopy (data not shown).
Discussion
Histochemists have long known that the glomerulus is rich in
anionic sites for it stains with cationic reactants as colloidal iron
and alcian blue [34, 35]. Chang et al [8] and Rennke, Cotran and
Venkatachalam [1] have demonstrated the functional role for
these anionic sites, the former by showing that the glomerular
clearance of negatively charged dextrans was reduced when
compared to that of neutral dextrans of the same size, and the
latter by determining that the penetration of cationized ferritin
molecules in the GBM was deeper than that of neutral or
anionic ferritin molecules of the same size. Subsequently, it has
been shown [4, 36, 37] by biochemical analysis and by enzyme
digestion studies that the anionic sites of the GBM are localized
in the laminae rarae interna and externa and mainly consist of
sulfated glycosaminoglycans, such as heparan sulfate. Sialic
acid present at the surface of endothelial and epithelial cells and
in GBM glycoproteins (laminin, for example) is another
polyanion of the glomerular filtration barrier [10]. Its removal
by neuraminidase perfusion of rat kidneys determine a disap-
pearance of the electronegative charges present at the surface
of endothelial and epithelial cells and a detachment of those
cells from the GBM, similar to that seen in aminonucleoside
nephrosis [10].
In diseased states, the loss of electronegative charges from
the glomerular filtration barrier have been demonstrated by
clearance studies of variously charged dextrans or by histo-
chemical analysis performed either in rats presenting with a
nephrotoxic nephritis or an aminonucleoside nephrosis [5, 9,
38], or in patients presenting with an acquired or a congenital
nephrotic syndrome [39, 40]. Michael, Blau and Vernier [5]
have noticed in the aminonucleoside nephrosis of rats that the
decrease in the glomerular sialoprotein content coincides with
the onset of proteinuria and the foot—process fusion. Vernier et
al [40] have suggested that congenital nephrosis results from
failure of heparan sulfate—rich anionic sites to normally develop
in the lamina rara externa of the GBM. More recently,
Kerjaschki, Vernillo and Farquhar [41] have demonstrated that
the sialic acid content of podocalyxin, the major sialylated rat
glomerular protein, is reduced by 30% in aminonucleoside
nephrosis.
In the present work, we have demonstrated that in rats
presenting with a severe proteinuria: (1) the urinary laminin
excretion is strongly increased; (2) this increase is temporally
correlated with the loss of the glomerular colloidal iron staining
at pH 1.9 [5]; and (3) the urinary excretion of laminin runs
parallel with that of type IV collagen, a glycoprotein located, as
laminin, in the GBM and in other basement membranes. The
plasma levels of laminin and type IV collagen were not mea-
sured in the present work. One cannot therefore exclude that
some laminin and type IV collagen antigens found in urine
might come from other basement membranes than the GBM.
However, puromycin aminonueleoside and anti-GBM antibod-
ies primarily cause glomerular damage [5, 181. Accordingly, we
suggest that in both groups of rats, laminin molecules are well
removed from the glomerular filtration barrier. The absence of
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a clear cut alteration of the binding of anti-laminin antibodies to
the GBM of diseased kidneys, as observed by immunofluores-
cence microscopy, does not really argue against this interpre-
tation since it is well known that the definition of im-
munofluorescence techniques is rather poor. Ultrastructural
studies of kidney sections incubated with anti-laminin antibod-
ies coated to gold particles are now being pursued to clarify this
point. Further studies will be also necessary to know whether
the loss of laminin molecules is important or not in the overall
electro-negativity of the GBM.
Several works [16, 19, 42] have shown that neutral
proteinases generated by mesangial cells, monocytes and neu-
trophils are implicated in the physiological turnover and/or in
the increased degradation of GBM glycoproteins in vivo. We
have demonstrated in both experimental models of glomerular
disease that: (1) the urinary excretion of neutral proteinases is
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Table 1. Effect of potential inhibitors on urinary neutral proteinase
activity
Agent
Activity (%)
Normal rats A rat&' B ratsb
None 100 100 100
EDTA, 2 mri 100 51.6 2.4 59.1 5.2
Cysteine, 2 mr't 100 52.8 1.2 49.8 2.6
SBTI, 500 ,.Lg/ml 22.4 2.8a 49.8 3.9 48.6 3.9
PMS-F, 1 mrvi 15.1 4.1 47.1 2.8 56.2 4.2
Aprotinin, 1 mgl,nl 19.2 1.4 51.8 3.6 52.3 2.9
EDTA, 2 mM and
PMS-F, 1 mrvi 13.8 2.6 9.1 0.4 10.1 0.6
a Enzymatic activity is expressed as a percentage of activity in the
absence of inhibitors. Data are given as mean SEM (N = 4)
b A rats, rats injected with anti-GBM IgG; B rats, rats injected with
aminonucleoside
Table 2. Degradation of laminin and type IV collagen by urine from
normal or nephrotic rats
Degradation in 48 hr, %
'4C-labelled type 3H-
Origin of urine IV collagen laminin
Normal 15.1 3.2 21.6 2.9
A rats' 52.6 4.8 67.7 3.8
B ratsb 54.4 3.6 69.6 4.1
Control urineb 3.4 1.6 4.7 1.9
a Results are expressed as the percentage of laminin or of type IV
collagen content of control urines. Data are given as the mean SEM
(N = 4). The percentage of degradation of laminin or of type IV
collagen is higher in A or B rats than in normal rats (P < 0.01).
b A rats, rats injected with anti-GBM IgG; B rats, rats injected with
aminonucleoside; control urine, urine samples supplemented with
PMS-F 1 m and EDTA 2 mri
Milliunits/mI Table 3. Correlation between the urinary neutral proteinase activity
Ferritin BSA Cytochrome C and the intensity of stain for glomerular polyanion at varying time
I I intervals in four normal rats, four rats injected with nephrotoxic
serum (A rats) and four rats injected with aminonucleoside (B rats)
Urinary Intensity of
Group of
rats
Days
after
injection
Urine
protein
mg/24 hr
neutral
proteinase
activity
U/24 hr
glomerular
staining
with colloidal
iron pH 1.9
Control 1 5 3.6 3 +
A 1 7 2.7 3+
B 1 8 6.1 3+
Control 3 9 6.4 3 +
A 3 164 32.1 Trace
B 3 10 8.9 3+
Control 4 10 5.2 3 +
A 4 172 62.2 Trace
B 10 138 45.6 Trace
Control 5 8 6.7 3 +
A 5 107 24.1 Trace
B 11 129 37.2 Trace
excretion of laminin and type IV collagen; and (4) urine from
diseased rats is capable of degrading to a greater extent that
normal urine labelled laminin and type IV collagen in vitro.
Although the association between the proteinuria and the
enhanced urinary excretion of laminin, type IV collagen and
neutral proteinases may simply be coincidental, our data also
support the concept [16, 19, 42] that neutral proteinases may
play a role in the damage to the GBM.
We have noted that proteinases found in urine from normal or
nephrotic rats are neutral proteinases since they exert their
optimal activity at pH 7.4. Furthermore, inhibition experiments
have shown that, in normal rats, those enzymatic activities
mainly result from serine—type proteinases (inhibition by PMS-
F, SBTI and aprotinin, but no inhibition by EDTA and cysteine)
whereas, in proteinuric rats, they mainly result from both
serine—type proteinases and metalloproteinases (inhibition by
PMS-F, SBTI, aprotinin, EDTA and cysteine).
20
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>.
>
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Fig. 7. Determination of the apparent molecular weight of urinary
proteinases by gel chromatography on a 1.6 x 60 cm Sephacryl S-200
SF column calibrated with ferritin, bovine serum albumine, and
cytochrome C. Fractions of 2 ml were collected and tested for protein-
ase activity. The proteinase activity peak exhibits an apparent molec-
ular weight of about 30,000.
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Fig. 8. Determination of isoelectric point of urinary proteinases by
chromatofocusing on a 1.6 x 40 cm column packed with PBE 94 gel.
The start buffer was 0.025 M ethanolamine—CH3 COOH pH 9.4,
whereas the eluent used was a polybuffer 96—CH3 COOH pH 6.
Fractions of 2 ml were collected, exhaustively dialyzed against 0.01 M
phosphate—buffered saline pH 7.4 and tested for proteinase activity.
The greatest enzymatic activity (O---O) was observed in a fraction
eluted at pH (I—•) 9.0.
strongly increased; (2) these neutral proteinases are "active"
since they are capable of degrading laminin and type IV
collagen in vitro; (3) the urinary excretion of those enzymes is
significantly correlated with the proteinuria and with the urinary
What is the origin of neutral proteinases found in urine from
nephrotic rats? A bacterial contamination is highly improbable
since urine samples from normal and nephrotic rats are simi-
larly processed and sterilized by filtration through Millipore
Urinary neutral proteinase activity 39
filters before being stored at —20°C. Although they may not
necessarily be the same in the two groups of rats studied, the
following sources of urinary proteinases must be considered:
the plasma, the phagocytic cells infiltrating the glomeruli and
the intrinsic kidney cells. It is well known that the plasma
contains serine—type proteinases. Besides, a metalloproteinase
has been also recently detected in patients presenting with
acute and chronic renal failure [43]. A role for plasma protein-
ases in the degradation of GBM is therefore possible despite the
fact that their action is theoretically counteracted by the pres-
ence of strong plasma enzyme inhibitors [20]. Indeed, Mayer et
al [44] have demonstrated that during the aminonucleoside
nephrosis in rat, no change occurred in the serum protease
activity whereas the serum antiprotease capacity declined co-
incidently with proteinuria. A relative excess of enzymes over
inhibitors might then occur in the vicinity of the GBM. The
contribution of such a mechanism to glomerular damage cannot
be appreciated in the present study, since both protease and
antiprotease activities were not measured in the serum of
nephrotic rats. Polymorphonuclear leukocytes and mononu-
clear phagocytes are responsible for glomerular injury in ani-
mals with various immunologically induced glomerulonephritis
by the selective release of lysosomal enzymes directly on the
GBM [18—20, 45]. Furthermore, the aminonucleoside of
puromycin can induce an in vivo release of proteases from
leukocytes [46]. The morphological aspect of glomerular le-
sions, however, suggests that the phagocytic cells are much
more probably implicated in A rats than in B rats. In this latter
group indeed, no phagocytic cells are detectable in glomeruli
during the course of the disease [26], whereas in A rats, some
mononuclear phagocytes infiltrating the glomeruli two to five
days after the injection of anti-GBM IgG are in close contact
with the GBM [181. It seems, therefore, reasonable to suggest
that serine—type proteinases locally secreted by those cells may
contribute to glomerular damage in rats presenting with a
proliferative glomerular disease. On the contrary, a major role
for mononuclear cells in the production of neutral metal-
loproteinases can be excluded since they can only release
serine—type proteinases [20]. Finally, other possible sources of
neutral proteinases are represented by intrinsic glomerular and
tubular cells, which are well supplied with lysosomal hydro-
lases [44, 47]. It has been shown indeed that: (a) lysosomes are
dramatically increased in both glomerular and proximal tubular
cells during the aminonucleoside nephrosis [26]; (b) both
glomerular and tubular lesions are obvious during the acceler-
ated model of nephrotoxic nephritis three to 14 days after the
injection of anti-GBM IgG [181; (c) the mesangial cells can
produce in vitro metalloproteinases capable of degrading, at
physiological pH, purified rat GBM [16].
In summary, the experiments described in this paper were
conducted to provide a support to the concept that neutral
proteinases may contribute to GBM damage in rats presenting
with a proliferative or a non-proliferative glomerular disease.
Our in vivo and in vitro findings have shown that the protein-
uria, the urinary excretion of basement membrane components
and the urinary excretion of neutral proteinases are significantly
correlated in both experimental models. It is therefore possible
that metalloproteinases and/or serine—type proteinases from
different sources may play a role in the development of protein-
uria by their direct action on the glomerular filtration barrier.
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